Evidence map›Paper›PMID 34073890›Full record

ArticleInternational journal of molecular sciences2021

Bisphenol A Inhibits the Transporter Function of the Blood-Brain Barrier by Directly Interacting with the ABC Transporter Breast Cancer Resistance Protein (BCRP).

Elin Engdahl, Maarten D M van Schijndel, Dimitrios Voulgaris, Michela Di Criscio, Kerry A Ramsbottom, Daniel J Rigden, Anna Herland, Joëlle Rüegg

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Elin EngdahlEnvironmental Toxicology, Department of Organismal Biology, Uppsala University, 75236 Uppsala, Sweden.ORCID 0000-0003-2997-7643
Maarten D M van SchijndelEnvironmental Toxicology, Department of Organismal Biology, Uppsala University, 75236 Uppsala, Sweden.
Dimitrios VoulgarisDivision of Micro and Nanosystems, Department of Intelligent Systems, KTH Royal Institute of Technology, 11428 Stockholm, Sweden.ORCID 0000-0003-4574-1702
Michela Di CriscioEnvironmental Toxicology, Department of Organismal Biology, Uppsala University, 75236 Uppsala, Sweden.ORCID 0000-0002-3964-460X
Kerry A RamsbottomInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 3BX, UK.ORCID 0000-0002-7432-9293
Daniel J RigdenInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 3BX, UK.ORCID 0000-0002-7565-8937
Anna HerlandDivision of Micro and Nanosystems, Department of Intelligent Systems, KTH Royal Institute of Technology, 11428 Stockholm, Sweden.ORCID 0000-0002-5002-2537
Joëlle RüeggEnvironmental Toxicology, Department of Organismal Biology, Uppsala University, 75236 Uppsala, Sweden.
Uppsala University · SEKarolinska Institutet · SEUniversity of Liverpool · GB

Funding

Svenska Forskningsrådet Formas 2017-00513
6 · The paper itself

Abstract

The breast cancer resistance protein (BCRP) is an important efflux transporter in the blood-brain barrier (BBB), protecting the brain from a wide range of substances. In this study, we investigated if BCRP function is affected by bisphenol A (BPA), a high production volume chemical used in common consumer products, as well as by bisphenol F (BPF) and bisphenol S (BPS), which are used to substitute BPA. We employed a transwell-based in vitro cell model of iPSC-derived brain microvascular endothelial cells, where BCRP function was assessed by measuring the intracellular accumulation of its substrate Hoechst 33342. Additionally, we used in silico modelling to predict if the bisphenols could directly interact with BCRP. Our results showed that BPA significantly inhibits the transport function of BCRP. Additionally, BPA was predicted to bind to the cavity that is targeted by known BCRP inhibitors. Taken together, our findings demonstrate that BPA inhibits BCRP function in vitro, probably by direct interaction with the transporter. This effect might contribute to BPA's known impact on neurodevelopment.

Indexed as

ATP Binding Cassette Transporter, Subfamily G, Member 2Benzhydryl CompoundsBenzimidazolesBisphenol A CompoundsBisphenol F CompoundsBisphenol S CompoundsBlood-Brain BarrierCell Culture TechniquesCells, CulturedDiketopiperazinesEndothelial CellsGene ExpressionHeterocyclic Compounds, 4 or More RingsHumansInduced Pluripotent Stem CellsIn Vitro Techniques3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl esterABCG2 protein, humanATP Binding Cassette Transporter, Subfamily G, Member 2Benzhydryl CompoundsBenzimidazolesbisbenzimide ethoxide trihydrochloridebisphenol ABisphenol A Compoundsbisphenol FBisphenol F Compoundsbisphenol SBisphenol S CompoundsDiketopiperazinesHeterocyclic Compounds, 4 or More RingsNeoplasm ProteinsPhenolsSulfonesABCG2BBBBCRPbisphenolsblood-brain barrierBPABPFBPSbreast cancer resistance protein

Identifiers

PMID34073890
PMCPMC8197233
OpenAlexW3164849528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.